Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Chemotherapy
Interventions: DRUG: Taxotere , Epirubicin|DRUG: E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP
Sponsor: National Taiwan University Hospital